+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of adverse effects of drugs in outpatients with extrapyramidal syndromes



Evaluation of adverse effects of drugs in outpatients with extrapyramidal syndromes



Semaine des Hopitaux 62(22): 1583-1587




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028282483

Download citation: RISBibTeXText


Related references

Criteria for use of agents for extrapyramidal adverse effects in adult, adolescent, and child inpatients and outpatients. Clinical Pharmacy 11(6): 553-556, 1992

Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs. Psychiatria Polska 8(2): 143-148, 1974

Extrapyramidal syndromes and other neurological side effects of psychotropic drugs. Lipton, Morris A , Alberto Dimascio And Keith F Killam (Ed ) Psychopharmacology: A Generation Of Progress Xxviii+1731p Illus Raven Press: New York, N Y , Usa ISBN 0-89004-191-1: 1021-1032, 1978

Adverse effects of antiepileptic drugs in North Indian pediatric outpatients. Clinical Neuropharmacology 36(4): 107-113, 2014

Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol : Results of the EIRE Study. Clinical Drug Investigation 22(9): 609-622, 2002

Role of anti cholinergic drugs in extrapyramidal syndromes. Neuropharmacology 20(12 Part B): 1315-1318, 1981

Intolerance to neuroleptic drugs: The art of avoiding extrapyramidal syndromes. European Psychiatry 10(Suppl. 1): 27S-31S, 1995

Acute-onset extrapyramidal syndromes caused by drugs. Boletin Medico del Hospital Infantil de Mexico 38(4): 607-615, 1981

Amantadine in extrapyramidal syndromes induced by neuroleptic drugs. Nordisk Psykiatrisk Tidsskrift. Nordic Journal of Psychiatry 27(1): 31-34, 1973

When does the extrapyramidal syndrome become an adverse reaction to major psychotropic drugs?. Revista de Medicina Interna Neurologie Psihiatrie Neurochirurgie Dermato-Venerologie. Neurologie Psihiatrie Neurochirurgie 23(2): 131-134, 1978

Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. British Journal of Psychiatry. Supplement 1996(29): 32-39, 1996

Notes apropos of extrapyramidal type syndromes following psychotropic drugs and their corrective agents. Annales Medico-Psychologiques 120(1): 947-949, 1962

Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used). Therapeutique 48(9): 561-568, 1972

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effects in humans A re-evaluation of savoxepine. Society for Neuroscience Abstracts 20(1-2): 1639, 1994

Decreased extrapyramidal side effects and polypsichopharmacy in family practice outpatients. Boletin de la Asociacion Medica de Puerto Rico 75(8): 351-352, 1983